Maven Securities’s Evolent Health EVH Stock Holding History

Maven Securities’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,000	Closed	-$272K	–	1006
2023 Q3	$272K	Hold	10,000	–	–	﹤0.01%	969
2023 Q2	$303K	Hold	10,000	–	–	﹤0.01%	728
2023 Q1	$325K	Hold	10,000	–	–	0.01%	769
2022 Q4	$281K	Buy	10,000 +2,500	+33%	+$71.7K	0.01%	720
2022 Q3	$270K	Buy	+7,500	New	+$264K	0.01%	966
2022 Q1	–	Sell	-10,000	Closed	-$277K	–	1005
2021 Q4	$277K	Hold	10,000	–	–	0.01%	706
2021 Q3	$310K	Buy	+10,000	New	+$240K	0.01%	821

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Maven Securities's EVH Position: Q4 2023 in Review

Maven Securities sold out of Evolent Health (EVH) in Q4 2023, closing a stake of 10,000 shares — an estimated $272K sold.

Maven Securities first reported a position in EVH in Q3 2021 and held it in 7 quarters. The position peaked at $325K in Q1 2023. 234 funds tracked by Wall St. Rank hold EVH as of Q4 2023.

Maven Securities reported no remaining Evolent Health position as of Q4 2023 after selling out during the quarter.
Maven Securities sold 10,000 Evolent Health shares in Q4 2023, an estimated $272K.
Maven Securities first reported a position in Evolent Health in Q3 2021 and held it in 7 quarters.
Maven Securities's Evolent Health position peaked at $325K in Q1 2023.
234 funds tracked by Wall St. Rank held Evolent Health as of Q4 2023.

Based on Maven Securities's 13F filing for Q4 2023, filed 12 Feb 2024.